Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Chung Yin Kong"'
Publikováno v:
Radiology. 300:586-593
Background Guidelines such as the Lung CT Screening Reporting and Data System (Lung-RADS) are available for determining when subsolid nodules should be treated within lung cancer screening programs, but they are based on expert opinion. Purpose To ev
Autor:
Joel H. Rubenstein, Amir-Houshang Omidvari, Brianna N. Lauren, William D. Hazelton, Francesca Lim, Sarah Xinhui Tan, Chung Yin Kong, Minyi Lee, Ayman Ali, Chin Hur, John M. Inadomi, Georg Luebeck, Iris Lansdorp-Vogelaar
Publikováno v:
Gastroenterology, 163(1), 163-173. W.B. Saunders
Gastroenterology
Gastroenterology
Background & Aims: Guidelines suggest endoscopic screening for esophageal adenocarcinoma (EAC) among individuals with symptoms of gastroesophageal reflux disease (GERD) and additional risk factors. We aimed to determine at what age to perform screeni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee41fbe65cb9f5119c5fd3696b0bd8ad
https://pure.eur.nl/en/publications/64701bca-121d-4a2c-a0da-aedb53d4c419
https://pure.eur.nl/en/publications/64701bca-121d-4a2c-a0da-aedb53d4c419
Autor:
Amanda Leiter, Chung Yin Kong, Michael K. Gould, Minal S. Kale, Rajwanth R. Veluswamy, Cardinale B. Smith, Grace Mhango, Brian Z. Huang, Juan P. Wisnivesky, Keith Sigel
Publikováno v:
PloS one. 17(11)
Background Randomized controlled trials (RCTs) have demonstrated a survival benefit for adjuvant platinum-based chemotherapy after resection of locoregional non-small cell lung cancer (NSCLC). The relative benefits and harms and optimal approach to t
Autor:
Keith Sigel, Chung Yin Kong, Amanda Leiter, Minal Kale, Grace Mhango, Brian Huang, Michael K. Gould, Juan Wisnivesky
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 170
Non-small cell lung cancer (NSCLC) patients frequently have major comorbidities but there is scarce data regarding the impact of these conditions on management strategies. We used simulation modeling to compare different treatments for stage I NSCLC
Autor:
Gonçalo Forjaz, Meghan J. Mooradian, Kathleen A. Cronin, Rafael Meza, Eric J. Feuer, Angela B. Mariotto, Nadia Howlader, Douglas R. Lowy, Chung Yin Kong
Publikováno v:
N Engl J Med
BACKGROUND: Lung cancer is made up of distinct subtypes, including non–small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Although overall mortality from lung cancer has been declining in the United States, little is known about mort
Autor:
Kevin ten Haaf, Jihyoun Jeon, Erik F. Blom, Sylvia K. Plevritis, Iakovos Toumazis, Pianpian Cao, Summer S. Han, Mehrad Bastani, Harry J. de Koning, Chung Yin Kong, Martin C. Tammemägi, Rafael Meza, Eric J. Feuer
Publikováno v:
Journal of the National Cancer Institute, 112(5):djz164, 466-479. Oxford University Press
J Natl Cancer Inst
J Natl Cancer Inst
Background Risk-prediction models have been proposed to select individuals for lung cancer screening. However, their long-term effects are uncertain. This study evaluates long-term benefits and harms of risk-based screening compared with current Unit
Publikováno v:
Radiology. 293:441-448
Background Subsolid pulmonary nodules, comprising pure ground-glass nodules (GGNs) and part-solid nodules (PSNs), have a high risk of indolent malignancy. Lung Imaging Reporting and Data System (Lung-RADS) nodule management guidelines are based on ex
Autor:
Lauren Palazzo, Angela C. Tramontano, Nathaniel D. Mercaldo, Andrew Eckel, Tina R. Watson, Yufan Chen, Ying Wang, Chung Yin Kong, Steven D. Criss
Publikováno v:
The Oncologist. 25:e120-e129
Background The end-of-life period is a crucial time in lung cancer care. To have a better understanding of the racial-ethnic disparities in health care expenditures, access, and quality, we evaluated these disparities specifically in the end-of-life
Publikováno v:
Cancer Medicine, Vol 8, Iss 11, Pp 5158-5172 (2019)
Cancer Medicine
Cancer Medicine
Background Detailed cost estimates are not widely available for esophageal cancer. Our study estimates phase‐specific costs for esophageal cancer by age, year, histology, stage, and treatment for older patients in the United States and compares the
Autor:
Deirdre F. Sheehan, Lauren E. Cipriano, Chin Hur, Yufan Chen, Angela C. Tramontano, Lauren Palazzo, Andrew Eckel, Chung Yin Kong, Steven D. Criss
Publikováno v:
Cancer Medicine
Background We studied trends in lung cancer treatment cost over time by phase of care, treatment strategy, age, stage at diagnosis, and histology. Methods Using the Surveillance, Epidemiology, and End Results (SEER)‐Medicare database for years 1998